ARN

CSC’s acquisition of iSoft approved by European Commission

Only approval by shareholders and final Court assent left to realise deal

CSC’s (NYSE: CSC) acquisition of healthcare IT solutions provider, iSoft (ASX:ISF), has been granted unconditional clearance by the European Commission to go ahead.

Since the deal has received clearance by the Commission, all that remains to complete the transaction is gaining the approval of shareholders and final Court assent in Australia.

CSC originally acquired all of the outstanding equity of iSoft via a court-approved scheme of arrangement in April, but there were fears that the deal might get derailed following the commencement of legal proceedings by iSoft founder Gary Cohen against investor Oceania Capital Partners in the same month.

Once completed, the acquisition of iSoft is expected to bolster CSC’s existing range of software products, services portfolio, and healthcare research and development capabilities.

Nominations for the 2012 ARN IT Industry Awards open on Tuesday, June 12.

More about: CSC, European Commission, iSoft, NYSE
References show all

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.
Users posting comments agree to the ARN comments policy.
Login or register to link comments to your user profile, or you may also post a comment without being logged in.
Related Coverage
Related Whitepapers
Latest Stories
Community Comments
Tags: csc, healthcare, iSOFT, IT solutions, Oceania Capital Partners, research and development, services, software
rhs_login_lockGet exclusive access to ARN's news, research and invitation only events.
ARN Distributor Directory
ARN Vendor Directory

iAsset is a channel management ecosystem that automates all major aspects of the entire sales,marketing and service process, including data tracking, integrated learning, knowledge management and product lifecycle management.